Attached files

file filename
10-Q - FORM 10-Q - ClearPoint Neuro, Inc.mrii_10q-033112.htm
EX-3.1 - EXHIBIT 3.1 - ClearPoint Neuro, Inc.ex3-1.htm
EX-3.2 - EXHIBIT 3.2 - ClearPoint Neuro, Inc.ex3-2.htm
EX-31.1 - EXHIBIT 31.1 - ClearPoint Neuro, Inc.ex31-1.htm
EX-31.2 - EXHIBIT 31.2 - ClearPoint Neuro, Inc.ex31-2.htm
EX-10.27 - EXHIBIT 10.27 - ClearPoint Neuro, Inc.ex10-27.htm
EXHIBIT 32
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND
CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13a-14(b) UNDER
THE SECURITIES EXCHANGE ACT OF 1934 AND SECTION 1350 OF
CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE
 
 
Each of the undersigned, Kimble L. Jenkins and David W. Carlson, certifies pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and Section 1350 of Chapter 63 of Title 18 of the United States Code, that (1) this quarterly report on Form 10-Q for the quarter ended March 31, 2012, of MRI Interventions, Inc. (the “Company”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, and (2) the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:  May 11, 2012
 
 
/s/ Kimble L. Jenkins
 
Kimble L. Jenkins
 
Chief Executive Officer
   
   
 
/s/  David W. Carlson
 
David W. Carlson
 
Chief Financial Officer